Bio Green Med Solution Inc. Common Stock (BGMS)

FairStock Score: 68/100 — STEADY

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

I look for businesses with durable economics, honest accounting, and a margin of safety. Bio Green Med Solution does not yet show that. It distributes and installs fire-safety materials and equipment and also pursues pharmaceutical research—two very different activities. In fiscal Q2 2026, the quarter ended 2026-06-30, it reported revenue of $336,000 and a net loss of $405,000, a negative 120.54% margin. In fiscal Q1 2026, the quarter ended 2026-03-31, revenue was $778,000 and net loss $197,000. For full fiscal 2025, revenue was $747,000 and net loss $3.0 million, or diluted EPS of -$6.45. Full fiscal 2024 had revenue of $43,000 and a net loss of $11.2 million, or diluted EPS -$502.46; full fiscal 2023 lost $22.6 million. The Lynch category is none, because it lost money in each of the last four years. FairStock calculates a P/B of 0.85 and a negative P/E of -0.19 at the 2026-10-13 close. No debt (D/E 0.00) is a small plus, and ROE of 34.40% looks odd against negative ROCE of -37.00%. Free cash flow is -$1.1 million, a -18.0% FCF yield, and the Altman Z-Score of -75.17 and Piotroski F-Score of 3/9 point to financial fragility. The price may appear low versus book value, but without consistent profits or cash generation, I see speculation, not a margin of safety. Growth from a tiny base is possible, but proof remains absent.

In plain English: Bio Green Med Solution sells and installs fire-safety materials and equipment and also does drug research. The business looks weak because it has lost money in each of the last four years and brings in only tiny revenue. At $0.92, the shares may look inexpensive against some financial measures, but with continuing losses there is no clear proof the price is truly a bargain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K/A (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer